Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.42 |
| ▸ | PRKCI | P41743 | 1/20 | 0.42 |
| ▸ | FURIN | P09958 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 2/20 | 0.38 |
| ▸ | NOS1 | P29475 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DDO | Q99489 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1976289 | 0.94 | CA5A (0.52) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL10066340 | 0.85 | TSHR (0.55) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL4730653 | 0.85 | FURIN (0.45) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL12666031 | 0.85 | TPMT (0.50) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL17635528 | 0.84 | CA5A (0.43) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL15338597 | 0.84 | CA5A (0.43) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL13307461 | 0.80 | CA5A (0.40) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL14192216 | 0.80 | CA5A (0.40) | CA5AMAPTRAB9ANPC1LMNA | |
| SCHEMBL4731090 | 0.80 | CA12 (0.50) | MAPTLMNACREBBPKDM4EALDH1A1 | |
| SCHEMBL12187779 | 0.80 | CA5A (0.40) | CA5AMAPTRAB9ANPC1CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136703-A | Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound | 三菱瓦斯化学株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-120136704-A | Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound | 三菱瓦斯化学株式会社 | 2025-06-13 | — | — | CN | disclosed |
| US-20220348698-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND, AS WELL AS METHOD FOR PRODUCING IODINE-CONTAINING VINYL POLYMER AND ACETYLATED DERIVATIVE THEREOF | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-11-03 | — | — | US | disclosed |
| CN-114245792-A | Compound, polymer, composition for film formation, method for pattern formation, method for forming insulating film, method for producing compound, and method for producing iodine-containing vinyl polymer and acetylated derivative thereof | 三菱瓦斯化学株式会社 | 2022-03-25 | — | — | CN | disclosed |
| US-20220073722-A1 | COMPOSITION AND MOLDED ARTICLE | AKITA UNIVERSITY (JP) | 2022-03-10 | — | — | US | disclosed |
| US-20210060042-A1 | Patentiflorin A Analogs as Antiviral Agents | HONG KONG BAPTIST UNIVERSITY (HK) | 2021-03-04 | — | — | US | disclosed |
| WO-2021029395-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMING METHOD, METHOD FOR FORMING INSULATING FILM, METHOD FOR PRODUCING COMPOUND, IODINE-CONTAINING VINYL POLYMER AND METHOD FOR PRODUCING ACETYLATED DERIVATIVE OF SAME | 三菱瓦斯化学株式会社 | 2021-02-18 | — | — | WO | disclosed |
| WO-2021029395-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMING METHOD, METHOD FOR FORMING INSULATING FILM, METHOD FOR PRODUCING COMPOUND, IODINE-CONTAINING VINYL POLYMER AND METHOD FOR PRODUCING ACETYLATED DERIVATIVE OF SAME | 三菱瓦斯化学株式会社 | 2021-02-18 | — | — | WO | disclosed |
| US-10815369-B2 | Composition and molded article | AKITA UNIVERSITY (JP) | 2020-10-27 | — | — | US | disclosed |
| US-20190169415-A1 | COMPOSITION AND MOLDED ARTICLE | AKITA UNIVERSITY (JP) | 2019-06-06 | — | — | US | disclosed |
| US-7973031-B2 | Leukemia therapy ;myelodyspastic syndrome | NOVARTIS AG (CH) | 2011-07-05 | — | — | US | disclosed |
| US-20100184820-A1 | COMBINATIONS COMPRISING STAUROSPORINES | NOVARTIS AG (CH) | 2010-07-22 | — | — | US | disclosed |
| US-20100184820-A1 | COMBINATIONS COMPRISING STAUROSPORINES | NOVARTIS AG (CH) | 2010-07-22 | — | — | US | disclosed |
| US-20090286770-A1 | Use of Staurosporine Derivatives for the Treatment of Multiple Myeloma | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2009-11-19 | — | — | US | disclosed |
| US-20090286770-A1 | Use of Staurosporine Derivatives for the Treatment of Multiple Myeloma | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2009-11-19 | — | — | US | disclosed |
| US-20080159954-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG RADICAL, PROCESSES FOR THEIR PREPARATION, AND THEIR USE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2008-07-03 | — | — | US | disclosed |
| US-20070299049-A1 | Pharmaceutical Uses of Staurosporine Derivatives | NOVARTIS PHARMACEUTICALS CORPORATION | 2007-12-27 | — | — | US | disclosed |
| US-20070299049-A1 | Pharmaceutical Uses of Staurosporine Derivatives | NOVARTIS PHARMACEUTICALS CORPORATION | 2007-12-27 | — | — | US | disclosed |
| US-7163997-B2 | Polyether derivative and process for producing the same | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-16 | — | — | US | disclosed |
| US-7163997-B2 | Polyether derivative and process for producing the same | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080159954-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG RADICAL, PROCESSES FOR THEIR PREPARATION, AND THEIR USE | TFRC, FCGRT, SLC39A14 | CA5A 3177/4885MAPT 470/4885RAB9A 1108/4885 |
| US-20090286770-A1 | Use of Staurosporine Derivatives for the Treatment of Multiple Myeloma | FOS, MYC, MCL1 | CA5A 2302/4885MAPT 3608/4885RAB9A 2800/4885 |
| US-20070299049-A1 | Pharmaceutical Uses of Staurosporine Derivatives | BAK1, BAD, MAST1 | CA5A 1029/4885MAPT 1468/4885RAB9A 3366/4885 |
| US-20100184820-A1 | COMBINATIONS COMPRISING STAUROSPORINES | MCL1, FLT3, BCL3 | CA5A 3918/4885MAPT 4300/4885RAB9A 4667/4885 |
| US-20210060042-A1 | Patentiflorin A Analogs as Antiviral Agents | MAVS, MIF, SARS1 | CA5A 2924/4885MAPT 2419/4885RAB9A 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.